Abstract: The present application discloses methods of making anti-G-CSF antibodies, anti-G-CSF antibodies, methods of screening the activity of anti-G-CSF antibodies, pharmaceutical compositions of anti-G-CSF antibodies, kits containing anti-G-CSF antibodies, and methods of using anti-G-CSF antibodies to treat a disease.
Type:
Application
Filed:
February 7, 2018
Publication date:
May 25, 2023
Applicant:
ME THERAPEUTICS INC.
Inventors:
Salim DHANJI, John PRIATEL, Kenneth HARDER